British Journal of Cancer - Table of Contents alert Volume 105 Issue 9

TABLE OF CONTENTS Volume 105, Issue 9 (1253-1468) Published online 25 October 2011 In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Letters to the Editor Corrigendum Also new today Advance online publication Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement British Journal of Cancer presents: Web Focus on Angiogenesis Angiogenesis is important for tumour growth and metastasis and is a key target for therapy. Greater understanding of the biology of angiogenesis has highlighted new targets for therapy and key interactions with VEGF, providing new avenues for improving the therapeutic performance of anti-VEGF therapies. This collection brings together a selection of key articles recently published in BJC. Read the articles for FREE   Minireview Top Stem cells, quiescence and rectal carcinoma: an unexplored relationship and potential therapeutic target S Buczacki, R J Davies and D J Winton Br J Cancer 2011 105: 1253-1259; advance online publication, September 20, 2011; 10.1038/bjc.2011.362 Abstract | Full Text Clinical Studies Top Adjuvant chemotherapy in older women (ACTION) study – what did we learn from the pilot phase? R Leonard, R Ballinger, D Cameron, P Ellis, L Fallowfield, M Gosney, L Johnson, L S Kilburn, A Makris, J Mansi, M Reed, A Ring, A Robinson, P Simmonds, G Thomas and J M Bliss Br J Cancer 2011 105: 1260-1266; advance online publication, October 11, 2011; 10.1038/bjc.2011.377 Abstract | Full Text Randomised, phase III trial of epoetin-β to treat chemotherapy-induced anaemia according to the EU regulation Y Fujisaka, T Sugiyama, H Saito, S Nagase, S Kudoh, M Endo, H Sakai, Y Ohashi and N Saijo Br J Cancer 2011 105: 1267-1272; advance online publication, September 29, 2011; 10.1038/bjc.2011.395 Abstract | Full Text Cost-effectiveness analysis of trastuzumab to treat HER2-positive advanced gastric cancer based on the randomised ToGA trial T Shiroiwa, T Fukuda and K Shimozuma Br J Cancer 2011 105: 1273-1278; advance online publication, September 29, 2011; 10.1038/bjc.2011.390 Abstract | Full Text Risk factors for short- and long-term complications after groin surgery in vulvar cancer F Hinten, L C G van den Einden, J C M Hendriks, A G J van der Zee, J Bulten, L F A G Massuger, H P van de Nieuwenhof and J A de Hullu Br J Cancer 2011 105: 1279-1287; advance online publication, October 4, 2011; 10.1038/bjc.2011.407 Abstract | Full Text Long-term survival of young women receiving fertility-sparing surgery for ovarian cancer in comparison with those undergoing radical surgery H Kajiyama, K Shibata, M Mizuno, T Umezu, S Suzuki, A Nawa, M Kawai, T Nagasaka and F Kikkawa Br J Cancer 2011 105: 1288-1294; advance online publication, October 4, 2011; 10.1038/bjc.2011.394 Abstract | Full Text Translational Therapeutics Top Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy M Keidar, R Walk, A Shashurin, P Srinivasan, A Sandler, S Dasgupta, R Ravi, R Guerrero-Preston and B Trink Br J Cancer 2011 105: 1295-1301; advance online publication, October 6, 2011; 10.1038/bjc.2011.386 Abstract | Full Text Adenoviruses-mediated transduction of human oesophageal carcinoma cells with the interferon-λ genes produced anti-tumour effects Q Li, K Kawamura, S Okamoto, H Fujie, M Numasaki, M Namba, M Nagata, H Shimada, H Kobayashi and M Tagawa Br J Cancer 2011 105: 1302-1312; advance online publication, September 27, 2011; 10.1038/bjc.2011.379 Abstract | Full Text PTEN regulates colorectal epithelial apoptosis through Cdc42 signalling R Deevi, A Fatehullah, I Jagan, M Nagaraju, V Bingham and F C Campbell Br J Cancer 2011 105: 1313-1321; advance online publication, September 27, 2011; 10.1038/bjc.2011.384 Abstract | Full Text Overexpression of cIAP2 contributes to 5-FU resistance and a poor prognosis in oral squamous cell carcinoma M Nagata, H Nakayama, T Tanaka, R Yoshida, Y Yoshitake, D Fukuma, K Kawahara, Y Nakagawa, K Ota, A Hiraki and M Shinohara Br J Cancer 2011 105: 1322-1330; advance online publication, September 27, 2011; 10.1038/bjc.2011.387 Abstract | Full Text Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer N Tanaka, A Miyajima, T Kosaka, Y Miyazaki, S Shirotake, H Shirakawa, E Kikuchi and M Oya Br J Cancer 2011 105: 1331-1337; advance online publication, October 4, 2011; 10.1038/bjc.2011.399 Abstract | Full Text Molecular Diagnostics Top Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer A Lecharpentier, P Vielh, P Perez-Moreno, D Planchard, J C Soria and F Farace Br J Cancer 2011 105: 1338-1341; advance online publication, October 4, 2011; 10.1038/bjc.2011.405 Abstract | Full Text Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence score S Sahebjam, R Aloyz, D Pilavdzic, M-L Brisson, C Ferrario, N Bouganim, V Cohen, W H Miller, Jr and L C Panasci Br J Cancer 2011 105: 1342-1345; advance online publication, October 4, 2011; 10.1038/bjc.2011.402 Abstract | Full Text Expression and prognostic value of transcription factor PROX1 in colorectal cancer M Skog, P Bono, M Lundin, J Lundin, J Louhimo, N Linder, T V Petrova, L C Andersson, H Joensuu, K Alitalo and C H Haglund Br J Cancer 2011 105: 1346-1351; advance online publication, October 4, 2011; 10.1038/bjc.2011.297 Abstract | Full Text Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma C-H Gattolliat, L Thomas, S A Ciafrè, G Meurice, G Le Teuff, B Job, C Richon, V Combaret, P Dessen, D Valteau-Couanet, E May, P Busson, S Douc-Rasy and J Bénard Br J Cancer 2011 105: 1352-1361; advance online publication, October 4, 2011; 10.1038/bjc.2011.388 Abstract | Full Text Upregulated FGFR1 expression is associated with the transition of hormone-naive to castrate-resistant prostate cancer K Armstrong, I Ahmad, G Kalna, S S Tan, J Edwards, C N Robson and H Y Leung Br J Cancer 2011 105: 1362-1369; advance online publication, September 27, 2011; 10.1038/bjc.2011.367 Abstract | Full Text A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures N S Sandanayake, J Sinclair, F Andreola, M H Chapman, A Xue, G J Webster, A Clarkson, A Gill, I D Norton, R C Smith, J F Timms and S P Pereira Br J Cancer 2011 105: 1370-1378; advance online publication, October 4, 2011; 10.1038/bjc.2011.376 Abstract | Full Text Low ANXA10 expression is associated with disease aggressiveness in bladder cancer P P Munksgaard, F Mansilla, A-S Brems Eskildsen, N Fristrup, K Birkenkamp-Demtröder, B P Ulhøi, M Borre, M Agerbæk, G G Hermann, T F Ørntoft and L Dyrskjøt Br J Cancer 2011 105: 1379-1387; advance online publication, October 6, 2011; 10.1038/bjc.2011.404 Abstract | Full Text Epidemiology Top Effects of annual vs triennial mammography interval on breast cancer incidence and mortality in ages 40–49 in Finland I Parvinen, S Chiu, L Pylkkänen, P Klemi, P Immonen-Räihä, L Kauhava, N Malila and M Hakama Br J Cancer 2011 105: 1388-1391; advance online publication, September 20, 2011; 10.1038/bjc.2011.372 Abstract | Full Text Association of rib anomalies and childhood cancers H Zierhut, M Murati, T Holm, E Hoggard and L G Spector Br J Cancer 2011 105: 1392-1395; advance online publication, September 13, 2011; 10.1038/bjc.2011.366 Abstract | Full Text Birth characteristics and childhood carcinomas K J Johnson, S E Carozza, E J Chow, E E Fox, S Horel, C C McLaughlin, B A Mueller, S E Puumala, P Reynolds, J Von Behren and L G Spector Br J Cancer 2011 105: 1396-1401; advance online publication, September 13, 2011; 10.1038/bjc.2011.359 Abstract | Full Text Survival from childhood cancer in northern England, 1968–2005 N O Basta, P W James, B Gomez-Pozo, A W Craft and R J Q McNally Br J Cancer 2011 105: 1402-1408; advance online publication, September 20, 2011; 10.1038/bjc.2011.341 Abstract | Full Text Risk of childhood acute lymphoblastic leukaemia following parental occupational exposure to extremely low frequency electromagnetic fields A Reid, D C Glass, H D Bailey, E Milne, N H de Klerk, P Downie and L Fritschi for the Aus-ALL Consortium Br J Cancer 2011 105: 1409-1413; advance online publication, September 13, 2011; 10.1038/bjc.2011.365 Abstract | Full Text Age, gender, and racial differences in incidence and survival in primary CNS lymphoma J L Villano, M Koshy, H Shaikh, T A Dolecek and B J McCarthy Br J Cancer 2011 105: 1414-1418; advance online publication, September 13, 2011; 10.1038/bjc.2011.357 Abstract | Full Text Increase in stroke risk in patients with head and neck cancer: a retrospective cohort study C-N Chu, S-W Chen, L-Y Bai, C-H Mou, C Y Hsu and F-C Sung Br J Cancer 2011 105: 1419-1423; advance online publication, September 13, 2011; 10.1038/bjc.2011.361 Abstract | Full Text Metabolic syndrome and insulin resistance in relation to biliary tract cancer and stone risks: a population-based study in Shanghai, China F M Shebl, G Andreotti, T E Meyer, Y-T Gao, A Rashid, K Yu, M-C Shen, B-S Wang, T-Q Han, B-H Zhang, F Z Stanczyk and A W Hsing Br J Cancer 2011 105: 1424-1429; advance online publication, September 13, 2011; 10.1038/bjc.2011.363 Abstract | Full Text Smoking as an independent risk factor for hepatocellular carcinoma: the Singapore Chinese Health Study W-P Koh, K Robien, R Wang, S Govindarajan, J-M Yuan and M C Yu Br J Cancer 2011 105: 1430-1435; advance online publication, September 13, 2011; 10.1038/bjc.2011.360 Abstract | Full Text Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition K K Tsilidis, N E Allen, T J Key, L Dossus, A Lukanova, K Bakken, E Lund, A Fournier, K Overvad, L Hansen, A Tjønneland, V Fedirko, S Rinaldi, I Romieu, F Clavel-Chapelon, P Engel, R Kaaks, M Schütze, A Steffen, C Bamia, A Trichopoulou, D Zylis, G Masala, V Pala, R Galasso, R Tumino, C Sacerdote, H B Bueno-de-Mesquita, F J B van Duijnhoven, M G M Braem, N C Onland-Moret, I T Gram, L Rodríguez, N Travier, M-J Sánchez, J M Huerta, E Ardanaz, N Larrañaga, K Jirström, J Manjer, A Idahl, N Ohlson, K-T Khaw, N Wareham, T Mouw, T Norat and E Riboli Br J Cancer 2011 105: 1436-1442; advance online publication, September 13, 2011; 10.1038/bjc.2011.371 Abstract | Full Text Physical activity and breast cancer risk in Chinese women A Pronk, B-T Ji, X-O Shu, W-H Chow, S Xue, G Yang, H-L Li, N Rothman, Y-T Gao, W Zheng and C E Matthews Br J Cancer 2011 105: 1443-1450; advance online publication, September 20, 2011; 10.1038/bjc.2011.370 Abstract | Full Text Premenopausal endogenous oestrogen levels and breast cancer risk: a meta-analysis K Walker, D J Bratton and C Frost Br J Cancer 2011 105: 1451-1457; advance online publication, September 13, 2011; 10.1038/bjc.2011.358 Abstract | Full Text Postmenopausal circulating levels of 2- and 16α-hydroxyestrone and risk of endometrial cancer A Zeleniuch-Jacquotte, R E Shore, Y Afanasyeva, A Lukanova, S Sieri, K L Koenig, A Idahl, V Krogh, M Liu, N Ohlson, P Muti, A A Arslan, P Lenner, F Berrino, G Hallmans, P Toniolo and E Lundin Br J Cancer 2011 105: 1458-1464; advance online publication, September 27, 2011; 10.1038/bjc.2011.381 Abstract | Full Text Letters to the Editor Top Comment on ‘Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab’ H Shimokawa, H Uramoto and F Tanaka Br J Cancer 2011 105: 1465-1466; advance online publication, October 11, 2011; 10.1038/bjc.2011.412 Full Text Reply: ‘Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab’ A Gualberto, M L Hixon and M Pollak Br J Cancer 2011 105: 1467; advance online publication, October 11, 2011; 10.1038/bjc.2011.413 Full Text Corrigendum Top Objective assessment of tumour response to therapy based on tumour growth kinetics E Mehrara, E Forssell-Aronsson and P Bernhardt Br J Cancer 2011 105: 1468; 10.1038/bjc.2011.436 Full Text Advertisement Ensure your access to British Journal of Cancer If you are unable to access the articles in this Table of Contents e-alert, your library may not subscribe to this journal. Our online recommendation form is a simple way to make your librarian aware that this journal is valuable to your research. Recommend now at http://www.nature.com/librec/svc/request/makeCommRequest?id=2.   Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.